论文部分内容阅读
近日,刊登在国际杂志Cell上的一项研究论文中,来自法国Gustave Roussy癌症研究中心的研究人员发表了题为“Microbiome and Anticancer Immunosurveillance”的一篇研究报告,文章中研究者揭示了微生物组和机体抗癌免疫监视之间的关联。从19世纪晚些时候,研究癌症和微生物之间的关联就已经成为科学界的研究重点了,从那时开始临床肿瘤学家等研究人员就已经开始尝试分离微生物产物及制剂来治疗多种人类疾病,比如基于减毒牛分枝杆菌而开发的表浅性膀胱癌疗法,以及利用溶瘤疱疹病毒治疗黑色素瘤的新型疗法等。
Recently, in a research paper published in the International Cell Cell, researchers from the Gustave Roussy Cancer Research Center in France published a study entitled “Microbiome and Anticancer Immunosurveillance”, in which researchers revealed that microbes The association between the group and the body’s anti-cancer immune surveillance. Since the late 19th century, the study of the link between cancer and micro-organisms has become the scientific community’s focus, and since then researchers such as clinical oncologists have begun to try to separate microbial products and preparations to treat a variety of human Diseases such as superficial bladder cancer therapy developed on the basis of attenuated M. bovis, and novel therapies that utilize oncolytic herpesvirus to treat melanoma.